Endometrial carcinoma in a breast cancer patient treated with tamoxifen

  • Authors: M Varras, G Zachos, D Spandidos
  • View Affiliations

  • Published online on: Monday, September 1, 1997
  • Pages: 1045-1046
  • DOI: 10.3892/or.4.5.1045

Abstract

The use of tamoxifen for breast cancer therapy is linked to an increased danger of developing endometrial neoplasias in postmenopausal patients receiving the drug. Understanding the molecular mechanisms of the tumorigenic activity of tamoxifen may be of great prognostic and therapeutic significance. Our study suggests that tamoxifen treatment and alterations of the K-ras proto-oncogene may occur as parallel events in carcinogenesis of the endometrium.
Journal Cover

September 1997
Volume 4 Issue 5

Print ISSN: 1021-335X
Online ISSN:1791-2431

2012 Impact Factor: 2.297
Ranked #36/196 Oncology
(total number of cites)

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Varras, M., Zachos, G., & Spandidos, D. (1997). Endometrial carcinoma in a breast cancer patient treated with tamoxifen. Oncology Reports, 4(5), 1045-1046.
MLA
Varras, Zachos, and D Spandidos. "Endometrial carcinoma in a breast cancer patient treated with tamoxifen." Oncology Reports Oncology Reports 4.5 (1997): 1045-1046.
Chicago
Varras, Zachos, and D Spandidos. "Endometrial carcinoma in a breast cancer patient treated with tamoxifen." Oncology Reports Oncology Reports 4 no. 5 (1997): 1045-1046.